Industry Verticals »

All Categories

Insights »

About TMR »

Rare Neurodegenerative Disease Treatment Market

Rare Neurodegenerative Disease Treatment Market (Indication: Multiple Sclerosis [MS], Alzheimer’s Disease, Parkinson's Disease, Acute Migraine, Autism, Narcolepsy, Amyotrophic Lateral Sclerosis [ALS], Attention Deficit Hyperactivity Disorder [ADHD], Spinal Muscular Atrophy, Tourette Syndrome, Huntington's Disease, and Others; Drug Class: Neurotransmitter Agents, Neuroprotective Agents, Biologics, and Others; and Distribution Channel: Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

Emergence of New Medical Approaches and Efforts to Improve Collaborative Research Networks to Aid Market Growth

The healthcare sector around the world is compelled to address a host of challenges, ranging from the onset of a pandemic to the discovery of new drugs and treatments for different diseases and medical conditions. One of the major areas within the healthcare sphere that continues to attract immense attention is that of the rare neurodegenerative disease treatment and the growing prevalence of several rare diseases worldwide. In addition, the prevalence of the rare neurodegenerative diseases has witnessed a gradual growth over the past couple of decades, owing to surge in the aging population, fast-paced urban lifestyle, etc.

Research and development activities have played an imperative role in enabling the growth of the biomedical research space and informatics due to which, understanding the epigenetic modifications, nutrition, and microbiome impact on health has improved considerably. Technological advancements and availability of computational facilities for large-scale analysis have also played an essential role in fueling the growth of the rare neurodegenerative disease treatment market– a trend that is expected to continue during the forecast period. In addition, the emergence of new medical approaches and ongoing efforts to improve collaborative networks across healthcare facilities are other major factors that are likely to propel the growth of the rare neurodegenerative disease treatment market in the forthcoming decade.

Increasing government support, private investments toward the development of new treatments and therapeutics, and demand for personalized treatment programs is likely to deeply influence the growth trajectory of the market for rare neurodegenerative disease treatment in the upcoming years. At the back of these factors, the global rare neurodegenerative disease treatment market is expected to attain a market value of US$ 116.3 Bn by the end of 2030.

Research Activities to Shape Future of Rare Neurodegenerative Disease Treatment

Over the past few decades, researchers, scientists, and other experts across the healthcare sector have come together to discover new therapies and medications for different rare neurodegenerative diseases. Research and development activities have shifted gears in the past decade due to which, the growth of the global rare neurodegenerative disease treatment market is projected to remain consistent in the upcoming years. In several regions, regulatory authorities, along with leading research organizations have enabled a host of research projects to move forward and thereby, offer promising advancements in the field of rare neurodegenerative disease treatment. For instance, the European Joint Programme on Rare Diseases (EJP RD) was primarily established to improve the overall efficiency and coordination among various research institutes working in tandem across the global rare neurodegenerative disease treatment market.

Research and development activities continue to focus on several key areas, including the development of novel therapeutics in a preclinical setting, leveraging disease models for improved drug development, and developing predictive and pharmacodynamics (PD) biomarkers in a preclinical setting. The overall growth of the global rare neurodegenerative disease treatment market is expected to be primarily driven by research and development activities. Although R&D activities have gained considerable momentum, market players are of the opinion that additional efforts and time are required to address several challenges across the rare diseases space.

Demand to Remain Steady amid COVID-19 Pandemic

The advent of the novel COVID-19 pandemic is anticipated to have a low impact on the overall growth of the global rare neurodegenerative disease treatment market. The healthcare bodies in different regions, along with local governments are increasingly seeking new approaches to address the medical conditions among patients suffering from rare diseases, including rare neurodegenerative diseases, as they are more vulnerable to the COVID-19 infection. Government personnel is increasingly focusing on providing access to high-quality and life-saving medications to patients suffering from rare diseases. While curbing the transmission of the novel COVID-19 virus is a top priority across the world, the U.S. FDA has also prioritized the development of new treatments for rare diseases. Moreover, governments in various developed regions of the world are also increasingly focusing on ensuring continuity of care for patients suffering from rare diseases such as global rare neurodegenerative disease. At present, governments across the world are seeking various avenues to improve the quality of treatment and access to these treatments for patients suffering from rare diseases during the COVID-19 pandemic.

Analysts’ Viewpoint

The global rare neurodegenerative disease treatment market is expected to expand at a moderate CAGR of ~5% during the forecast period. The market growth can be primarily attributed to factors such as growing prevalence of rare diseases worldwide, growing private investments, increasing support from governments, collaborations between research and medical institutes, and rising interest from the private sector. At present, research and development activities are likely to drive the global rare neurodegenerative disease treatment market.

Rare Neurodegenerative Disease Treatment Market: Overview

  • According to Transparency Market Research’s latest research report on the global rare neurodegenerative disease treatment market for the historical year (2018), base year (2019), and the forecast period (2020–2030), increase in incidence of neurological disorders is projected to drive the global rare neurodegenerative disease treatment market in the near future
  • According to the report, the global rare neurodegenerative disease treatment market was valued at US$ 67 Bn in 2019 and is anticipated to expand at a CAGR of ~5% from 2020 to 2030

Rise in Research & Development Programs to Drive Global Market

  • Rise in prevalence and increase in demand for newer drugs for the treatment of rare neurological disorders have led to the rise in research & development efforts followed by the introduction of innovative neurological disorder drugs. For instance, GlaxoSmithKline plc, Novartis AG, and Merck & Co. have comprehensive R&D programs, wherein these companies focus on the development of new therapeutics for the treatment of neurodegenerative diseases.
  • Increase in demand for neurological disorder drugs for treatment of Alzheimer’s disease and Parkinson’s disease, and rise in competition between key players are projected to boost the growth of the global rare neurological diseases treatment market. Leading players focus on research and development, with key technological improvements in drugs in order to fulfil customer demand.
  • In January 2020, Biogen, Inc. acquired a novel clinical stage asset, PF-05251749, along with the applications from Pfizer for US$ 75 Mn. The acquisition will strengthen Biogen’s existing pipeline of potential disease-modifying therapies in Alzheimer’s and Parkinson’s diseases, as PF-05251749 is a CNS-penetrant regulator that has the potential to treat behavioral and neurological symptoms across various psychiatric and neurological diseases.
  • In May 2019, Abbott Laboratories joined the National Institutes of Health's BRAIN Initiative to explore neuromodulation research. Therefore, rise in research & development programs and strategic decisions taken by various players augment the market.

Application of Precision Medicine in Neurodegenerative Diseases Propels Global Market

  • Precision medicine is data driven, and requires integration of clinical research, experimental biology, bioinformatics, and training of competent data scientists
  • MicroRNAs (miRNAs) have been extensively studied due to their implications in several disorders related to the central nervous system as well as for their potential role as biomarkers of diagnosis, prognosis, and response to treatment
  • Hence, the application of precision medicine in the treatment and prevention of neurodegenerative disorders appears to be highly promising in contrast to the traditional approach

High Cost of Treatment to Hamper Global Market

  • Cost of neurological disorder treatment is considerably high, owing to large quantity of antiepileptic, anticholinergic, and hypnotic & sedatives required. This is likely to hamper the global rare neurodegenerative disease treatment market.
  • Researchers found that out-of-pocket costs for multiple sclerosis drugs exhibited the steepest monthly increase. People taking this medication paid an average out-of-pocket cost of US$ 15 a month in 2004, compared to an average of US$ 309 a month in 2016.

Rare Neurodegenerative Disease Treatment Market: Competition Landscape

  • This report profiles major players operating in the global rare neurodegenerative disease treatment market based on attributes such as company overview, financial overview, product portfolio, major brands, business strategies, and recent developments
  • The global rare neurodegenerative disease treatment market is moderately fragmented, with the presence of a few large players in the international market and numerous small players in regional markets. The top players hold major share of the global rare neurodegenerative disease treatment market.
  • Prominent players operating in the global rare neurodegenerative disease treatment market include 
    • Allergan plc
    • Bayer AG, F
    • Hoffmann-La Roche Ltd.
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Merck KGaA
    • Novartis AG
    • Pfizer, Inc.
    • Sanofi
    • Teva Pharmaceutical Industries Ltd.
  • The report on the global rare neurodegenerative disease treatment market discusses individual strategies, followed by company profiles of manufacturers of rare neurodegenerative disease treatment drugs and therapies. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global rare neurodegenerative disease treatment market.

Frequently Asked Questions

What is the total market worth of rare neurodegenerative disease treatment market?

Rare neurodegenerative disease treatment market is expected to attain a market value of US$ 116.3 Bn by 2030

What would be the CAGR of the rare neurodegenerative disease treatment market during the forecast period?

Rare neurodegenerative disease treatment market is anticipated to expand at a CAGR of ~5% from 2020 to 2030

What are the key factors driving the rare neurodegenerative disease treatment market?

Rare neurodegenerative disease treatment market is driven by increase in incidence of neurological disorders

Which is the rising prominent segment in the rare neurodegenerative disease treatment market?

The multiple sclerosis (MS) segment dominated the global rare neurodegenerative disease treatment market and the trend is projected to continue during the forecast period

Who are the key players in the rare neurodegenerative disease treatment market?

Key players in the global rare neurodegenerative disease treatment market include Allergan plc, Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Johnson & Johnson

1. Executive Summary: Global Glycerol Carbonate Market

    1.1. Global Glycerol Carbonate Market Volume (Kilo Tons) Forecast, 2019–2030

    1.2. Global Glycerol Carbonate Market Value (US$ Mn) Forecast, by Region, 2019–2030

    1.3. Trends Impacting Market

    1.4. TMR’s Growth Opportunity Wheel

2. Market Overview

    2.1. Glycerol Carbonate: Application Definitions 

    2.2. Glycerol Carbonate: End-use Definitions

    2.3. Market Indicator

    2.4. Market Dynamics

        2.4.1. Drivers

        2.4.2. Restraints

        2.4.3. Key Opportunities 

    2.5. Porter’s Five Forces Analysis

    2.6. Regulations 

    2.7. Value Chain Analysis 

        2.7.1. List of Manufacturers

        2.7.2. List of Potential Customers 

    2.8. Regulatory Landscape 

3. Market Outlook for Glycerol Carbonate-based Chemicals 

    3.1. Polycarbonate

    3.2. Polyurethane

    3.3. Polyamides

    3.4. Polyesters

    3.5. Glycidol

4. Impact of COVID-19 on Global Glycerol Carbonate Market 

5. Production Output Analysis, 2019

6. Pricing Analysis

    6.1. Pricing Analysis, by Region

7. Global Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030 

    7.1. Global Glycerol Carbonate Market Analysis, by Application, 2019–2030

        7.1.1. Key Findings 

    7.2. Global Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030

        7.2.1. Solvents

        7.2.2. Fuel Additives

        7.2.3. Monomers

        7.2.4. Chemical Intermediates

        7.2.5. Others

    7.3. Global Glycerol Carbonate Market Analysis, by End-use, 2019–2030

        7.3.1. Key Findings 

    7.4. Global Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030 

        7.4.1. Detergents

        7.4.2. Cements

        7.4.3. Fuels

        7.4.4. Paints & Coatings

        7.4.5. Plastics

        7.4.6. Others

8. Global Glycerol Carbonate Market Analysis, by Region, 2019–2030

    8.1. Key Findings 

    8.2. Global Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Region, 2019–2030

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Global Glycerol Carbonate Market Attractiveness Analysis, by Region

9. North America Glycerol Carbonate Market Analysis 

    9.1. Key Findings

    9.2. North America Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030

        9.2.1. Solvents

        9.2.2. Fuel Additives

        9.2.3. Monomers

        9.2.4. Chemical Intermediates

        9.2.5. Others

    9.3. North America Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030 

        9.3.1. Detergents

        9.3.2. Cements

        9.3.3. Fuels

        9.3.4. Paints & Coatings

        9.3.5. Plastics

        9.3.6. Others

    9.4. North America Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Country, 2019–2030

    9.5. U.S. Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030

        9.5.1. Solvents

        9.5.2. Fuel Additives

        9.5.3. Monomers

        9.5.4. Chemical Intermediates

        9.5.5. Others

    9.6. U.S. Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030

        9.6.1. Detergents

        9.6.2. Cements

        9.6.3. Fuels

        9.6.4. Paints & Coatings

        9.6.5. Plastics

        9.6.6. Others

    9.7. Canada Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030

        9.7.1. Solvents

        9.7.2. Fuel Additives

        9.7.3. Monomers

        9.7.4. Chemical Intermediates

        9.7.5. Others

    9.8. Canada Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030

        9.8.1. Detergents

        9.8.2. Cements

        9.8.3. Fuels

        9.8.4. Paints & Coatings

        9.8.5. Plastics

        9.8.6. Others

10. Europe Glycerol Carbonate Market Analysis 

    10.1. Key Findings

    10.2. Europe Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030

        10.2.1. Solvents

        10.2.2. Fuel Additives

        10.2.3. Monomers

        10.2.4. Chemical Intermediates

        10.2.5. Others

    10.3. Europe Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030 

        10.3.1. Detergents

        10.3.2. Cements

        10.3.3. Fuels

        10.3.4. Paints & Coatings

        10.3.5. Plastics

        10.3.6. Others

    10.4. Europe Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Country and Sub-region, 2019–2030

    10.5. Germany Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030

        10.5.1. Solvents

        10.5.2. Fuel Additives

        10.5.3. Monomers

        10.5.4. Chemical Intermediates

        10.5.5. Others

    10.6. Germany Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030

        10.6.1. Detergents

        10.6.2. Cements

        10.6.3. Fuels

        10.6.4. Paints & Coatings

        10.6.5. Plastics

        10.6.6. Others

    10.7. France Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030

        10.7.1. Solvents

        10.7.2. Fuel Additives

        10.7.3. Monomers

        10.7.4. Chemical Intermediates

        10.7.5. Others

    10.8. France Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030

        10.8.1. Detergents

        10.8.2. Cements

        10.8.3. Fuels

        10.8.4. Paints & Coatings

        10.8.5. Plastics

        10.8.6. Others

    10.9. U.K. Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030

        10.9.1. Solvents

        10.9.2. Fuel Additives

        10.9.3. Monomers

        10.9.4. Chemical Intermediates

        10.9.5. Others

    10.10. U.K. Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030

        10.10.1. Detergents

        10.10.2. Cements

        10.10.3. Fuels

        10.10.4. Paints & Coatings

        10.10.5. Plastics

        10.10.6. Others

    10.11. Italy Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030

        10.11.1. Solvents

        10.11.2. Fuel Additives

        10.11.3. Monomers

        10.11.4. Chemical Intermediates

        10.11.5. Others

    10.12. Italy Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030

        10.12.1. Detergents

        10.12.2. Cements

        10.12.3. Fuels

        10.12.4. Paints & Coatings

        10.12.5. Plastics

        10.12.6. Others

    10.13. Russia & CIS Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030

        10.13.1. Solvents

        10.13.2. Fuel Additives

        10.13.3. Monomers

        10.13.4. Chemical Intermediates

        10.13.5. Others

    10.14. Russia & CIS Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030

        10.14.1. Solvents

        10.14.2. Fuel Additives

        10.14.3. Monomers

        10.14.4. Chemical Intermediates

        10.14.5. Others

    10.15. Rest of Europe Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030

        10.15.1. Solvents

        10.15.2. Fuel Additives

        10.15.3. Monomers

        10.15.4. Chemical Intermediates

        10.15.5. Others

    10.16. Rest of Europe Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030

        10.16.1. Detergents

        10.16.2. Cements

        10.16.3. Fuels

        10.16.4. Paints & Coatings

        10.16.5. Plastics

        10.16.6. Others

    10.17. Europe Glycerol Carbonate Market Attractiveness Analysis

11. Asia Pacific Glycerol Carbonate Market Analysis 

    11.1. Key Findings

    11.2. Asia Pacific Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030

        11.2.1. Solvents

        11.2.2. Fuel Additives

        11.2.3. Monomers

        11.2.4. Chemical Intermediates

        11.2.5. Others

    11.3. Asia Pacific Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030 

        11.3.1. Detergents

        11.3.2. Cements

        11.3.3. Fuels

        11.3.4. Paints & Coatings

        11.3.5. Plastics

        11.3.6. Others

    11.4. Asia Pacific Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Country and Sub-region, 2019–2030

    11.5. China Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030

        11.5.1. Solvents

        11.5.2. Fuel Additives

        11.5.3. Monomers

        11.5.4. Chemical Intermediates

        11.5.5. Others

    11.6. China Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030

        11.6.1. Detergents

        11.6.2. Cements

        11.6.3. Fuels

        11.6.4. Paints & Coatings

        11.6.5. Plastics

        11.6.6. Others

    11.7. Japan Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030

        11.7.1. Solvents

        11.7.2. Fuel Additives

        11.7.3. Monomers

        11.7.4. Chemical Intermediates

        11.7.5. Others

    11.8. Japan Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030

        11.8.1. Detergents

        11.8.2. Cements

        11.8.3. Fuels

        11.8.4. Paints & Coatings

        11.8.5. Plastics

        11.8.6. Others

    11.9. India Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030

        11.9.1. Solvents

        11.9.2. Fuel Additives

        11.9.3. Monomers

        11.9.4. Chemical Intermediates

        11.9.5. Others

    11.10. India Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030

        11.10.1. Detergents

        11.10.2. Cements

        11.10.3. Fuels

        11.10.4. Paints & Coatings

        11.10.5. Plastics

        11.10.6. Others

    11.11. ASEAN Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030

        11.11.1. Solvents

        11.11.2. Fuel Additives

        11.11.3. Monomers

        11.11.4. Chemical Intermediates

        11.11.5. Others

    11.12. ASEAN Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030

        11.12.1. Detergents

        11.12.2. Cements

        11.12.3. Fuels

        11.12.4. Paints & Coatings

        11.12.5. Plastics

        11.12.6. Others

    11.13. Rest of Asia Pacific Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030

        11.13.1. Solvents

        11.13.2. Fuel Additives

        11.13.3. Monomers

        11.13.4. Chemical Intermediates

        11.13.5. Others

    11.14. Rest of Asia Pacific Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030

        11.14.1. Detergents

        11.14.2. Cements

        11.14.3. Fuels

        11.14.4. Paints & Coatings

        11.14.5. Plastics

        11.14.6. Others

    11.15. Asia Pacific Glycerol Carbonate Market Attractiveness Analysis

12. Latin America Glycerol Carbonate Market Analysis 

    12.1. Key Findings

    12.2. Latin America Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030

        12.2.1. Solvents

        12.2.2. Fuel Additives

        12.2.3. Monomers

        12.2.4. Chemical Intermediates

        12.2.5. Others

    12.3. Latin America Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030 

        12.3.1. Detergents

        12.3.2. Cements

        12.3.3. Fuels

        12.3.4. Paints & Coatings

        12.3.5. Plastics

        12.3.6. Others

    12.4. Latin America Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Country and Sub-region, 2019–2030

    12.5. Brazil Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030

        12.5.1. Solvents

        12.5.2. Fuel Additives

        12.5.3. Monomers

        12.5.4. Chemical Intermediates

        12.5.5. Others

    12.6. Brazil Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030

        12.6.1. Detergents

        12.6.2. Cements

        12.6.3. Fuels

        12.6.4. Paints & Coatings

        12.6.5. Plastics

        12.6.6. Others

    12.7. Mexico Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030

        12.7.1. Solvents

        12.7.2. Fuel Additives

        12.7.3. Monomers

        12.7.4. Chemical Intermediates

        12.7.5. Others

    12.8. Mexico Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030

        12.8.1. Detergents

        12.8.2. Cements

        12.8.3. Fuels

        12.8.4. Paints & Coatings

        12.8.5. Plastics

        12.8.6. Others

    12.9. Rest of Latin America Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030

        12.9.1. Solvents

        12.9.2. Fuel Additives

        12.9.3. Monomers

        12.9.4. Chemical Intermediates

        12.9.5. Others

    12.10. Rest of Latin America Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030

        12.10.1. Detergents

        12.10.2. Cements

        12.10.3. Fuels

        12.10.4. Paints & Coatings

        12.10.5. Plastics

        12.10.6. Others

    12.11. Latin America Glycerol Carbonate Market Attractiveness Analysis

13. Middle East & Africa Glycerol Carbonate Market Analysis 

    13.1. Key Findings

    13.2. Middle East & Africa Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030

        13.2.1. Solvents

        13.2.2. Fuel Additives

        13.2.3. Monomers

        13.2.4. Chemical Intermediates

        13.2.5. Others

    13.3. Middle East & Africa Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030 

        13.3.1. Detergents

        13.3.2. Cements

        13.3.3. Fuels

        13.3.4. Paints & Coatings

        13.3.5. Plastics

        13.3.6. Others

    13.4. Middle East & Africa Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Country and Sub-region, 2019–2030

    13.5. GCC Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030

        13.5.1. Solvents

        13.5.2. Fuel Additives

        13.5.3. Monomers

        13.5.4. Chemical Intermediates

        13.5.5. Others

    13.6. GCC Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030

        13.6.1. Detergents

        13.6.2. Cements

        13.6.3. Fuels

        13.6.4. Paints & Coatings

        13.6.5. Plastics

        13.6.6. Others

    13.7. South Africa Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030

        13.7.1. Solvents

        13.7.2. Fuel Additives

        13.7.3. Monomers

        13.7.4. Chemical Intermediates

        13.7.5. Others

    13.8. South Africa Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030

        13.8.1. Detergents

        13.8.2. Cements

        13.8.3. Fuels

        13.8.4. Paints & Coatings

        13.8.5. Plastics

        13.8.6. Others

    13.9. Rest of Middle East & Africa Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by Application, 2019–2030

        13.9.1. Solvents

        13.9.2. Fuel Additives

        13.9.3. Monomers

        13.9.4. Chemical Intermediates

        13.9.5. Others

    13.10. Rest of Middle East & Africa Glycerol Carbonate Market Volume (Kilo Tons) and Value (US$ Mn) Forecast, by End-use, 2019–2030

        13.10.1. Detergents

        13.10.2. Cements

        13.10.3. Fuels

        13.10.4. Paints & Coatings

        13.10.5. Plastics

        13.10.6. Others

    13.11. Middle East & Africa Glycerol Carbonate Market Attractiveness Analysis

14. Competition Landscape

    14.1. Global Glycerol Carbonate Market Share Analysis, by Company, 2019

    14.2. Competition Matrix

    14.3. Application Mapping

    14.4. Company Profiles

        14.4.1. Huntsman International LLC

            14.4.1.1. Company Details (HQ, Year of Establishment, Revenue, Employee Strength)

            14.4.1.2. Business Overview 

            14.4.1.3. Products/Services, Key End-use Industries

            14.4.1.4. Financial Overview 

        14.4.2. Eurisotop (Cambridge Isotope Laboratories, Inc. (CIL))

            14.4.2.1. Company Details (HQ, Year of Establishment, Revenue, Employee Strength)

            14.4.2.2. Business Overview 

            14.4.2.3. Products/Services, Key End-use Industries

        14.4.3. UBE Industries India Private Ltd.

            14.4.3.1. Company Details (HQ, Year of Establishment, Revenue, Employee Strength)

            14.4.3.2. Business Overview 

            14.4.3.3. Products/Services, Key End-use Industries

        14.4.4. Inkemia Green Chemicals Inc.

            14.4.4.1. Company Details (HQ, Year of Establishment, Revenue, Employee Strength)

            14.4.4.2. Business Overview 

            14.4.4.3. Products/Services, Key End-use Industries 

        14.4.5. TCI Chemicals (India) Pvt. Ltd.

            14.4.5.1. Company Details (HQ, Year of Establishment, Revenue, Employee Strength)

            14.4.5.2. Business Overview 

            14.4.5.3. Products/Services, Key End-use Industries 

        14.4.6. Carbone Scientific Co., Ltd.

            14.4.6.1. Company Details (HQ, Year of Establishment, Revenue, Employee Strength)

            14.4.6.2. Business Overview 

            14.4.6.3. Products/Services, Key End-use Industries 

        14.4.7. Acros Organics B.V.B.A. (Thermo Fisher Scientific Company)

            14.4.7.1. Company Details (HQ, Year of Establishment, Revenue, Employee Strength)

            14.4.7.2. Business Overview 

            14.4.7.3. Products/Services, Key End-use Industries

        14.4.8. GLACONCHEMIE GmbH

            14.4.8.1. Company Details (HQ, Year of Establishment, Revenue, Employee Strength)

            14.4.8.2. Business Overview 

            14.4.8.3. Products/Services, Key End-use Industries 

        14.4.9. ANHUI MEISENBAO CHEMICAL CO., LTD.

            14.4.9.1. Company Details (HQ, Year of Establishment, Revenue, Employee Strength)

            14.4.9.2. Business Overview 

            14.4.9.3. Products/Services, Key End-use Industries

15. Primary Research: Key Insights

16. Appendix

    16.1. Research Methodology and Assumptions 

List of Tables

Table 01 Global Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 02 Global Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 03 Global Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030

Table 04 Global Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 05 Global Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 06 North America Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 07 North America Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 08 North America Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 09 North America Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030

Table 10 North America Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 11 Europe Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 12 Europe Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 13 Europe Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 14 Europe Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030

Table 15 Europe Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 16 Asia Pacific Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 17 Asia Pacific Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 18 Asia Pacific Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 19 Asia Pacific Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030

Table 20 Asia Pacific Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 21 Latin America Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 22 Latin America Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 23 Latin America Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 24 Latin America Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030

Table 25 Latin America Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 26 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 27 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 28 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 29 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030

Table 30 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

List of Figures

Figure 01 Global Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast, 2018–203

Figure 02 Global Rare Neurodegenerative Disease Treatment Market Value Share, by Indication, 2019

Figure 03 Global Rare Neurodegenerative Disease Treatment Market Value Share, by Drug Class, 2019

Figure 04 Global Rare Neurodegenerative Disease Treatment Market Value Share, by Distribution Channel, 2019

Figure 05 Global Rare Neurodegenerative Disease Treatment Market Value Share, by Region, 2019

Figure 06 Global Rare Neurodegenerative Disease Market Value Share Analysis, by Indication, 2019 and 2030

Figure 07 Global Rare Neurodegenerative Disease Market Attractiveness Analysis, by Indication, 2020–2030

Figure 08 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Multiple Sclerosis (MS), 2018–2030

Figure 09 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Alzheimer’s Disease, 2018–2030

Figure 10 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Parkinson's Disease, 2018–2030

Figure 11 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Acute Migraine, 2018–2030

Figure 12 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Autism, 2018–2030

Figure 13 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Narcolepsy, 2018–2030

Figure 14 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Amyotrophic Lateral Sclerosis (ALS), 2018–2030

Figure 15 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Attention Deficit Hyperactivity Disorder (ADHD), 2018–2030

Figure 16 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Spinal Muscular Atrophy, 2018–2030

Figure 17 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Tourette Syndrome, 2018–2030

Figure 18 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Huntington's disease, 2018–2030

Figure 19 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Others, 2018–2030

Figure 20 Global Rare Neurodegenerative Disease Market Value Share Analysis, by Drug Class, 2019 and 2030

Figure 21 Global Rare Neurodegenerative Disease Market Attractiveness Analysis, by Drug Class, 2020–2030

Figure 22 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Neuroprotective Agents, 2018–2030

Figure 23 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Neurotransmitter Agents, 2018–2030

Figure 24 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Biologics, 2018–2030

Figure 25 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Others, 2018–2030

Figure 26 Global Rare Neurodegenerative Disease Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 27 Global Rare Neurodegenerative Disease Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 28 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Hospital Pharmacies, 2018–2030

Figure 29  Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Online Pharmacies, 2018–2030

Figure 30 Global Rare Neurodegenerative Disease Market Value (US$ Mn), by Retail Pharmacies, 2018–2030

Figure 31 Global Rare Neurodegenerative Disease Market Value Share Analysis, by Region, 2019 and 2030

Figure 32 Global Rare Neurodegenerative Disease Market Attractiveness Analysis, by Region, 2020–2030

Figure 33 North America Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 34 North America Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Country, 2019 and 2030

Figure 35 North America Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Country, 2020–2030

Figure 36 North America Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Indication, 2019 and 2030

Figure 37 North America Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Indication, 2019–2030

Figure 38 North America Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Drug Class, 2019 and 2030

Figure 39 North America Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Drug Class, 2020–2030

Figure 40 North America Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 41 North America Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 42 Europe Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 43 Europe Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019 and 2030

Figure 44 Europe Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2020–2030

Figure 45 Europe Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Indication, 2019 and 2030

Figure 46 Europe Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Indication, 2019–2030

Figure 47 Europe Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Drug Class, 2019 and 2030

Figure 48 Europe Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Drug Class, 2020–2030

Figure 49 Europe Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 50 Europe Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 51 Asia Pacific Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 52 Asia Pacific Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019 and 2030

Figure 53 Asia Pacific Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2020–2030

Figure 54 Asia Pacific Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Indication, 2019 and 2030

Figure 55 Asia Pacific Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Indication, 2019–2030

Figure 56 Asia Pacific Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Drug Class, 2019 and 2030

Figure 57 Asia Pacific Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Drug Class, 2020–2030

Figure 58 Asia Pacific Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 59 Asia Pacific Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 60 Latin America Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 61 Latin America Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019 and 2030

Figure 62 Latin America Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2020–2030

Figure 63 Latin America Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Indication, 2019 and 2030

Figure 64 Latin America Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Indication, 2019–2030

Figure 65 Latin America Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Drug Class, 2019 and 2030

Figure 66 Latin America Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Drug Class, 2020–2030

Figure 67 Latin America Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 68 Latin America Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 69 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 70 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019 and 2030

Figure 71 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2020–2030

Figure 72 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Indication, 2019 and 2030

Figure 73 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Indication, 2019–2030

Figure 74 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Drug Class, 2019 and 2030

Figure 75 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Drug Class, 2020–2030

Figure 76 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 77 Middle East & Africa Rare Neurodegenerative Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 78 Global Rare Neurodegenerative Disease Treatment Market Share Analysis, by Company, 2019

Copyright © Transparency Market Research, Inc. All Rights reserved

Rare Neurodegenerative Disease Treatment Market

Schedule a Call